EP1824855
Nýjar pýrrólo[3,2-d]pýrimídín-4-ónafleiður og notkun þeirra í meðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
5.12.2005EP published:
8.8.2012EP application number:
05812036.1
EP translation filed:
1.10.2012Grant published:
15.10.2012EPO information:
European Patent Register
Max expiry date:
4.12.2025Expiry date:
4.12.2016
Title:
Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy
Timeline
Today
5.12.2005EP application
8.8.2012EP Publication
1.10.2012Translation submitted
15.10.2012Registration published
4.12.2016Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
BÖGEVIG, AndersAddress:
S-151 85 Södertälje, SE
Name:
LO-ALFREDSSON, YvonneAddress:
S-151 85 Södertälje, SE
Name:
PIVONKA, DonaldAstraZeneca WilmingtonAddress:
Wilmington, DE, US
Name:
TIDÉN, Anna-KarinAddress:
S-151 85 Södertälje, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0402972Date:
6.12.2004Country:
SE
Number:
0501093Date:
13.5.2005Country:
SE
Classification
Categories:
C07D 487/04, A61K 31/519, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 8.11.2012
Expires: 4.12.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 6.11.2013
Expires: 4.12.2014
Payer: Árnason Faktor
Number: 10
Paid: 18.11.2014
Expires: 4.12.2015
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.11.2015
Expires: 4.12.2016
Payer: Sigurjónsson & Thor ehf.